If you're searching for a drug pricing database, you're usually trying to do something practical: look up a current drug price, compare manufacturers, check an NDC, or track how pricing has changed over time.
The problem is that many drug price sources are either too high-level, too opaque, or too focused on list prices that don't reflect what pharmacies actually pay. A useful database should help you move from a vague drug name to a specific product, price history, and market context quickly.
This guide explains what a drug pricing database should include, how to evaluate one, and how to use NADAC-based pricing data to search U.S. prescription drug prices by NDC, generic name, manufacturer, and therapeutic class.
Tip
Ready to search now? Start with drug search if you have an NDC or product name, use Drug Markets to compare all versions of a molecule, or check Trends to see where prices are moving this week.
Start Here in NADAC Intelligence
If your goal is to turn this research into action, these are the main product paths on the site:
- ●Search by NDC or drug name
- ●Compare drug markets
- ●Review manufacturers
- ●Browse therapeutic classes
- ●Track weekly price trends
- ●Set up alerts and exports
If you want a more specific workflow after this overview, go deeper with How to Compare Drug Prices by Manufacturer, Generic Drug Prices, or Drug Pricing API.
What Is a Drug Pricing Database?
A drug pricing database is a searchable source of prescription drug pricing information. Depending on the dataset, it may include:
- ●Current price per unit for a specific drug product
- ●Historical price changes over time
- ●NDC-level detail for individual package and labeler combinations
- ●Generic and brand product comparisons
- ●Manufacturer-level pricing differences
- ●Therapeutic class trends and market-wide movement
Some databases focus on list prices such as WAC or AWP. Others focus on reimbursement benchmarks. NADAC is different because it is designed to reflect pharmacy acquisition cost, which makes it more useful for reimbursement analysis, purchasing comparisons, and market trend monitoring.
Note
NADAC stands for National Average Drug Acquisition Cost. If you want the background on how CMS publishes it and why it matters, start with our guide to what NADAC pricing is.
What a Good Drug Pricing Database Should Let You Do
If someone lands on your site from the query "drug pricing database," their intent is usually transactional or research-driven. They want to answer one of a few concrete questions.
1. Search by NDC
The National Drug Code (NDC) is the most precise way to identify a drug product. A good drug pricing database should let you search by NDC so you can distinguish between:
- ●Different manufacturers of the same generic
- ●Different package sizes
- ●Different dosage forms or strengths
- ●Brand versus generic versions of similar products
On NADAC Intelligence, you can search directly from the homepage and drill into NDC-level detail to see current pricing and price history.
2. Search by Generic Name
Sometimes you do not know the NDC. You only know the drug name, such as semaglutide, metformin, or apixaban. A useful database should let you start with a generic name and then move into the broader market for that drug.
That is where a market-level view matters. Our Drug Markets section groups related NDCs so you can see how a drug market behaves overall instead of looking at a single package in isolation.
3. Compare Manufacturers
For multisource generics, the same active ingredient may be sold by many manufacturers. A strong drug pricing database should help you compare pricing by manufacturer to answer questions like:
- ●Which manufacturers currently price above or below the market average?
- ●How concentrated is this market?
- ●Are there lower-cost alternatives for the same generic?
That is exactly why we built the Manufacturer pages and manufacturer comparisons into the platform.
4. Track Historical Changes
A single price point is useful. A trend line is more useful. If you are evaluating a drug pricing database, make sure it can show you:
- ●Whether the price moved last week or last month
- ●Whether the move is isolated or part of a longer trend
- ●Which drugs or classes are currently most volatile
Our Trends pages and NDC-level history make it easier to spot price movement before it turns into a reimbursement or supply issue.
5. Compare Within a Therapeutic Class
Drug pricing decisions often happen at the class level, not just the product level. Analysts, pharmacy buyers, and consultants frequently want to compare pricing patterns across categories such as anticoagulants, insulins, or GLP-1s.
That is why a useful drug pricing database should also support class-level exploration, which you can do in our Therapeutic Classes section.
Why NADAC Is a Strong Foundation for a Drug Pricing Database
Many healthcare professionals search for a "drug pricing database" when they actually need a benchmark that reflects real market conditions more closely than list prices do.
NADAC is especially useful because it is based on pharmacy invoice survey data rather than a manufacturer-published sticker price. That means it is often more relevant for:
- ●Pharmacy reimbursement analysis
- ●Medicaid pricing research
- ●Generic market monitoring
- ●Wholesaler and acquisition cost benchmarking
- ●Longitudinal price trend analysis
This does not make NADAC the answer to every pricing question. It does make it one of the most practical public benchmarks for people who want a searchable, transparent view of retail drug acquisition cost.
Drug Pricing Database vs AWP, WAC, and Other Benchmarks
One reason people struggle to find a good drug pricing database is that the term covers several very different datasets.
| Benchmark | What It Represents | Best Use Case | | --- | --- | --- | | NADAC | Average pharmacy acquisition cost from invoice survey data | Reimbursement analysis, market monitoring, drug price lookup | | AWP | Manufacturer-reported reference price | Legacy reimbursement contracts, benchmark comparisons | | WAC | Manufacturer list price to wholesalers | Commercial contract review, list-price context | | MAC | Payer- or PBM-specific reimbursement ceiling | Payer-specific generic reimbursement analysis |
If your goal is to build or use a prescription drug pricing database for operational decision-making, NADAC is usually more actionable than AWP because it is closer to what pharmacies are actually paying.
If your real question is about the benchmark rather than the database workflow, continue with NADAC vs AWP, NADAC vs WAC, or the broader Pharmacy Reimbursement Benchmark guide.
How to Use NADAC Intelligence as a Drug Pricing Database
Here is a practical workflow for using the site as a drug pricing database.
Search by NDC or product name
If you know the product or NDC, start at the search page. This is the fastest path when you already have a concrete product in mind and want to get directly to current pricing and product-level history.
Compare the full drug market
If you want to understand all versions of a drug, go to Drug Markets. This is useful when the real question is not "What is the price of this one NDC?" but "What does the market for this molecule look like right now?" It is the best entry point when you want to compare price movement, market size, and competitive dynamics around a generic or brand market.
Compare manufacturers side by side
If you are comparing suppliers, move into Manufacturers to see which companies are active in the market and how their pricing compares. This is the fastest way to turn search traffic into a product workflow for sourcing and market review.
Find category-level movement
If you are screening for opportunity or volatility, use Therapeutic Classes or Trends to identify where pricing is moving fastest. If you are not starting with a specific product, these two pages are the quickest way to discover where action is happening.
Move from lookup to monitoring
If you need alerts, repeat monitoring, or export workflows rather than one-off lookups, the paid plans on Pricing cover that use case better than manual searching. For higher-intent visitors, this is the point where the drug pricing database becomes an ongoing operating tool rather than a one-time lookup.
Tip
The highest-intent users searching for a drug pricing database are often not casual readers. They usually want a tool they can return to repeatedly, which is why the best next step is usually one of these four product paths: search a drug, compare a drug market, review manufacturers, or monitor movement in trends.
Who Uses a Drug Pricing Database?
The phrase "drug pricing database" is broad, but the use cases are usually very specific.
Pharmacies
Pharmacy operators use pricing databases to check acquisition cost benchmarks, evaluate reimbursement pressure, and compare drug markets where margins are tightening.
Healthcare consultants and analysts
Consultants use drug pricing databases to support payer strategy, reimbursement analysis, market research, and client-facing reporting.
Medicaid and policy researchers
Researchers use NADAC-style datasets to study generic competition, price movement, and the impact of market structure on reimbursement.
Manufacturers and market intelligence teams
Commercial teams can use a drug pricing database to understand how specific markets are moving, where price compression is happening, and which categories deserve closer review.
What Makes a Drug Pricing Database Actually Useful?
There are plenty of places online where you can find a drug-related number. That does not automatically make them useful databases.
A practical drug pricing database should be:
- ●Searchable: You should be able to find drugs by NDC, generic name, and manufacturer
- ●Structured: Prices should be tied to real products and markets, not just keyword results
- ●Historical: You should be able to view trends, not just snapshots
- ●Transparent: The benchmark should be clear about what the number means
- ●Actionable: The data should support real workflows such as reimbursement review, market comparison, or monitoring
That is the gap NADAC Intelligence is trying to fill. We are not just publishing a static list of prices. We are organizing the NADAC dataset into a searchable drug pricing database designed for decision-making.
Frequently Asked Questions
Is there a free drug pricing database?
There are several public drug price sources, but many are hard to search or not designed for analysis. NADAC Intelligence offers free search and exploration across current pricing, drug markets, manufacturers, and class-level trends.
Can I search drug prices by NDC?
Yes. Searching by NDC is often the best way to find the exact product you care about, especially when multiple manufacturers or package sizes exist.
What is the difference between a drug pricing database and a drug cost benchmark?
A benchmark is the pricing reference itself, such as NADAC or WAC. A drug pricing database is the searchable system that organizes those benchmarks so users can look up products, compare markets, and analyze trends.
Is NADAC the same as AWP?
No. NADAC is based on pharmacy acquisition cost survey data, while AWP is a manufacturer-reported reference price. They serve different purposes and can differ materially.
Who should use a NADAC-based drug pricing database?
Pharmacies, analysts, consultants, Medicaid researchers, reimbursement teams, and healthcare operators all benefit from a NADAC-based database when they need market-reflective drug pricing data.
Tip
Use NADAC Intelligence to search by NDC or drug name, compare drug markets, review manufacturers, explore therapeutic classes, track weekly price changes, or move into alerts and exports on Pricing.
Final Takeaway
If you are looking for a drug pricing database, the right choice depends on what you need to search and what kind of pricing benchmark matters for your workflow. For many pharmacy, reimbursement, and market-analysis use cases, a NADAC-based drug pricing database is one of the most useful places to start because it helps connect product-level search to real market context.
Use NADAC Intelligence to search 60,000+ drugs, compare manufacturers, review therapeutic classes, and monitor weekly price movement across the U.S. prescription drug market.